Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
TrovaGene (TROV) Is Today's Strong On High Volume Stock
By TheStreet Wire
May 19, 2016 10:47 AM EDT
PRESS RELEASES
Trovagene Expands Board With Addition Of Three Industry Leaders - James Armitage, MD, Lâle White, And Gary Pace, PhD
By PR Newswire
Apr 22, 2020 8:30 AM EDT
PRESS RELEASES
Trovagene Announces Acceptance Of Phase 1b/2 KRAS-Mutated Metastatic Colorectal Cancer (mCRC) Trial Abstract For Presentation At The 2020 ASCO Annual Meeting
By PR Newswire
Apr 1, 2020 8:15 AM EDT
PRESS RELEASES
Trovagene Presents Phase 2 Data Demonstrating The Ability Of Onvansertib To Overcome Zytiga®-Resistance And Provide Clinical Benefit For MCRPC Patients
By PR Newswire
Feb 13, 2020 8:00 AM EST
PRESS RELEASES
Trovagene To Present New Clinical Data For Onvansertib In Metastatic Castration-Resistant Prostate Cancer At ASCO Genitourinary Cancers Symposium
By PR Newswire
Feb 5, 2020 8:00 AM EST
PRESS RELEASES
Trovagene Receives Approximately $1.45 Million From Exercise Of Warrants
By PR Newswire
Jan 29, 2020 8:00 AM EST
PRESS RELEASES
Onvasertib Demonstrates Effectiveness As Pan-KRAS Inhibitor With Confirmed Tumor Regression And Clinical Benefit Achieved In KRAS-Mutated MCRC Patients
By PR Newswire
Jan 27, 2020 8:00 AM EST
PRESS RELEASES
Trovagene To Present New Clinical Data For Onvansertib In Metastatic KRAS-Mutated Colorectal Cancer At ASCO 2020 Gastrointestinal Cancers Symposium
By PR Newswire
Jan 21, 2020 8:00 AM EST
MARKETS
TrovaGene (TROV) Is Today's Strong On High Volume Stock
By TheStreet Wire
May 19, 2016 10:47 AM EDT
MARKETS
Here’s Why TrovaGene (TROV) Stock is Soaring Today
By Kaya Yurieff
Feb 1, 2016 1:14 PM EST
MARKETS
TrovaGene (TROV) Is Weak On High Volume Today
By TheStreet Wire
Jan 22, 2016 10:07 AM EST
MARKETS
Trovagene (TROV) Stock Soars on America's Choice Provider Network Partnership
By Amanda Albright
Jan 21, 2016 2:28 PM EST
OPINION
5 Health Care Stocks Under $10 Set to Soar
By Roberto Pedone
Jul 23, 2015 11:49 AM EDT
MARKETS
TrovaGene (TROV) Stock Tanks After Pricing Secondary Offering
By Tony Owusu
Jul 17, 2015 3:16 PM EDT
MARKETS
TrovaGene (TROV) Highlighted As Weak On High Volume
By TheStreet Wire
Jul 17, 2015 10:02 AM EDT
MARKETS
TrovaGene (TROV) Is Weak On High Volume Today
By TheStreet Wire
Jun 25, 2015 10:06 AM EDT
MARKETS
TrovaGene (TROV) Is Weak On High Volume Today
By TheStreet Wire
Jun 15, 2015 10:03 AM EDT
JIM CRAMER
'Mad Money' Lightning Round: Caterpillar Is Troubled
By Scott Rutt
Jun 6, 2015 6:00 AM EDT
JIM CRAMER
Jim Cramer's 'Mad Money' Recap: Here's Next Week's Game Plan
By Scott Rutt
Jun 5, 2015 8:25 PM EDT
MARKETS
Trade-Ideas: TrovaGene (TROV) Is Today's Weak On High Relative Volume Stock
By Marissa Goodbody
Apr 23, 2015 10:01 AM EDT
MARKETS
TrovaGene (TROV) Strong On High Relative Volume Today
By David M. Aferiat
Apr 21, 2015 10:06 AM EDT
INVESTING
3 Biotech Stocks Under $10 in Breakout Territory: TrovaGene and More
By Roberto Pedone
Jan 29, 2015 1:06 PM EST
INVESTING
2 Health Care Stocks Rising on Big Volume
By Roberto Pedone
Aug 5, 2013 8:37 AM EDT
INVESTING
4 Stocks Under $10 Making Big Moves
By Roberto Pedone
Jun 28, 2013 7:21 AM EDT
INVESTING
3 Health Care Stocks Under $10 to Watch
By Roberto Pedone
May 7, 2013 2:23 PM EDT
